Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.
about
Suppression of renal cell carcinoma growth and metastasis with sustained antiangiogenic gene therapyThe role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis.Adenovirus-mediated restoration of expression of the tumor suppressor gene DLC1 inhibits the proliferation and tumorigenicity of aggressive, androgen-independent human prostate cancer cell lines: prospects for gene therapy.
P2860
Combination therapy of androgen-independent prostate cancer using a prostate restricted replicative adenovirus and a replication-defective adenovirus encoding human endostatin-angiostatin fusion gene.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@en
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@nl
type
label
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@en
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@nl
prefLabel
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@en
Combination therapy of androge ...... tatin-angiostatin fusion gene.
@nl
P2093
P1476
Combination therapy of androge ...... statin-angiostatin fusion gene
@en
P2093
Beth Elisa Juliar
Chinghai Kao
Liang Cheng
Meei-Huey Jeng
Sang-Don Lee
Sang-Jin Lee
Shaobo Zhang
Thomas A Gardner
Yan-Ping Zhang
P304
P356
10.1158/1535-7163.MCT-05-0339
P577
2006-03-01T00:00:00Z